The agency says the psychedelic drug shows promise despite addictiveness and short supply. The Food and Drug Administration (FDA) approved a new ketamine-based drug called KETARx for use…
Read MorePsychedelics
FDA Panel Votes Against First Proposed MDMA-Based Drug
Available data did not show a benefit to the PTSD patients for which it was intended. This week, a Food and Drug Administration (FDA) advisory panel voted against…
Read More